Article
Insight onto the pathophysiology and clinical complications of thalassemia intermedia.
Hemoglobin - 1 Jan 2009
Cappellini Maria D, Musallam Khaled M, Taher Ali T
Abstract excerpt
Our understanding of the molecular and pathophysiological mechanisms underlying the disease process in patients with thalassemia intermedia (TI) has substantially increased over the past decade. TI encompasses a wide clinical spectrum of beta-thalassemia phenotypes. Some TI patients are asymptomatic until adult life, whereas others are symptomatic from as young as 2 years. A number of clinical complications...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
